Impaired ('diabetic') insulin signaling and action occur in fat cells long before glucose intolerance - Is insulin resistance initiated in the adipose tissue?

International Journal of Obesity

Volumn 26, Issue 7, 2002, Pages 897-904

  Smith, Ulf ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

GLUT4; Insulin resistance; IRS 1; IRS 2; Type 2 diabetes

Indexed keywords

GLUCOSE; GLUCOSE TRANSPORTER 4; GLYCOGEN; INSULIN; INSULIN RECEPTOR SUBSTRATE 1; PROTEIN KINASE B;

ADIPOCYTE; ADIPOSE TISSUE; DIABETES MELLITUS; ENZYME ACTIVITY; GENE EXPRESSION; GENETIC PREDISPOSITION; GLUCOSE INTOLERANCE; GLUCOSE TRANSPORT; GLYCOGEN SYNTHESIS; HUMAN; INSULIN METABOLISM; INSULIN RESISTANCE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; SKELETAL MUSCLE;

ADIPOCYTES; DIABETES MELLITUS; DIABETES MELLITUS, TYPE 2; GLUCOSE INTOLERANCE; HUMANS; INSULIN; INSULIN RESISTANCE; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; PHOSPHOPROTEINS; SIGNAL TRANSDUCTION; THIAZOLES; THIAZOLIDINEDIONES;

EID: 0036310147     PISSN: 03070565     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.ijo.0802028     Document Type: Review

References (59)

1. Pathogenesis of NIDDM. A balanced overview
2. Alternative pathway of insulin signalling in mice with targeted disruption of the IRS-1 gene
3. Disruption of IRS-2 causes type 2 diabetes in mice
4. Targeted disruption of the glucose transporter 4 selectively in muscle causes insulin resistance and glucose intolerance
5. Adipose-selective targeting of the GLUT4 gene impairs insulin action in muscle and liver
6. Redistribution of substrates to adipose tissue promotes obesity in mice with selective insulin resistance in muscle
7. Insulin action and insulin resistance in human skeletal muscle
8. Normal insulin-dependent activation of Akt/protein kinase B, with diminished activation of phosphoinositide 3-kinase, in muscle in type 2 diabetes
9. Insulin-stimulated Akt kinase activity is reduced in skeletal muscle from NIDDM subjects
10. Expression of insulin-receptor substrate-1 and -2 in ovaries from women with insulin resistance and from controls
11. Insulin/IGF-1 and TNF-alpha stimulate phosphorylation of IRS-1 at inhibitory Ser307 via distinct pathways
12. Insulin action on glucose transport and plasma membrane GLUT4 content in skeletal muscle from patients with NIDDM
13. Effects of glycaemia on glucose transport in isolated skeletal muscle from patients with NIDDM: In vitro reversal of muscular insulin resistance
14. Tumor necrosis factor alpha inhibits signaling from the insulin receptor
15. Effects of free fatty acids on glucose transport and IRS-1-associated phosphatidylinositol 3-kinase activity
16. Evidence against altered expression of GLUT1 or GLUT4 in skeletal muscle of patients with obesity or NIDDM
17. Insulin receptor substrate (IRS) 1 is reduced and IRS-2 is the main docking protein for phosphatidylinositol 3-kinase in adipocytes from subjects with non-insulin-dependent diabetes mellitus
18. Impaired phosphorylation and insulin-stimulated translocation to the plasma membrane of protein kinase B/Akt in adipocytes from type II diabetic subjects
19. Gene expression of GLUT4 in skeletal muscle from insulin-resistant patients with obesity, IGT, GDM, and NIDDM
20. Decreased insulin activation of glycogen synthase in skeletal muscles in young nonobese Caucasian first-degree relatives of patients with non-insulin-dependent diabetes mellitus
21. Decreased tyrosine kinase activity in partially purified insulin receptors from muscle of young, non-obese first degree relatives of patients with type 2 (non-insulin-dependent) diabetes mellitus
22. Skeletal muscle insulin resistance in normoglycemic subjects with a strong family history of type 2 diabetes is associated with decreased insulin-stimulated insulin receptor substrate-1 tyrosine phosphorylation
23. Insulin signal transduction in skeletal muscle from glucose-intolerant relatives with type 2 diabetes
24. Insulin resistance differentially affects the PI 3-kinase- and MAP kinase-mediated signaling in human muscle
25. Insulin receptor phosphorylation, insulin receptor substrate-1 phosphorylation, and phosphatidylinositol 3-kinase activity are decreased in intact skeletal muscle strips from obese subjects
26. Insulin signaling and action in cultured skeletal muscle cells from lean healthy humans with high and low insulin sensitivity
27. Postabsorptive respiratory quotient and insulin-stimulated glucose storage rate in nondiabetic Pima Indians are related to glycogen synthase fractional activity in cultured myoblasts
28. Low cellular IRS 1 gene and protein expression predict insulin resistance and NIDDM
29. Insulin resistance with low cellular IRS-1 expression is also associated with low GLUT4 expression and impaired insulin-stimulated glucose transport
30. Obesity and heredity in the etiology of non-insulin-dependent diabetes mellitus in 32,662 adult white women
31. Family history of diabetes in relation to different types of obesity and change of obesity during 12-yr period. Results from prospective population study of women in Goteborg, Sweden
32. Family history of diabetes in middle-aged Swedish men is a gender unrelated factor which associates with insulinopenia in newly diagnosed diabetic subjects
33. Banting lecture 1988. Role of insulin resistance in human disease
34. Impaired glucose transport as a cause of decreased insulin-stimulated muscle glycogen synthesis in type 2 diabetes
35. Alterations in insulin signalling pathway induced by prolonged insulin treatment of 3T3-L1 adipocytes
36. Insulin-stimulated GLUT4 translocation requires the CAP-dependent activation of TC10
37. Tumor necrosis factor-alpha-induced insulin resistance in 3T3-L1 adipocytes is accompanied by a loss of insulin receptor substrate-1 and GLUT4 expression without a loss of insulin receptor-mediated signal transduction
38. Overexpression of perilipin A and B blocks the ability of tumor necrosis factor alpha to increase lipolysis in 3T3-L1 adipocytes
39. Tumor necrosis factor alpha stimulates lipolysis in adipocytes by decreasing Gi protein concentrations
40. The hormone resistin links obesity to diabetes
41. FIZZ1, a novel cysteine-rich secreted protein associated with pulmonary inflammation, defines a new gene family
42. Resistin/Fizz3 expression in relation to obesity and peroxisome proliferator-activated receptor-gamma action in humans
43. Insulin resistance and type 2 diabetes are not related to resistin expression in human fat cells or skeletal muscle
44. Leptin reverses insulin resistance and diabetes mellitus in mice with congenital lipodystrophy
45. Diseases of liporegulation: New perspective on obesity and related disorders
46. Surgical implantation of adipose tissue reverses diabetes in lipoatrophic mice
47. PPARgamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein
48. Secretion of adiponectin and regulation of apM1 gene expression in human visceral adipose tissue
49. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity
50. Treatment of insulin resistance with peroxisome proliferator-activated receptor gamma agonists
51. Thiazolidinediones (PPARgamma agonists) but not PPARalpha agonists increase IRS-2 gene expression in 3T3-L1 and human adipocytes
52. 4PS/insulin receptor substrate (IRS)-2 is the alternative substrate of the insulin receptor in IRS-1-deficient mice
53. Decreased IRS-2 and increased SREBP-1c lead to mixed insulin resistance and sensitivity in livers of lipodystrophic and ob/ob mice
54. Disruption of insulin receptor substrate 2 causes type 2 diabetes because of liver insulin resistance and lack of compensatory beta-cell hyperplasia
55. Irs-2 coordinates Igf-1 receptor-mediated beta-cell development and peripheral insulin signalling
56. Essential role of insulin receptor substrate 1 (IRS-1) and IRS-2 in adipocyte differentiation
57. PPARgamma: A nuclear regulator of metabolism, differentiation, and cell growth
58. Thiazolidinediones block tumor necrosis factor-alpha-induced inhibition of insulin signaling
59. Essential role of phosphatidylinositol 3-kinase in insulin-induced activation and phosphorylation of the cGMP-inhibited cAMP phosphodiesterase in rat adipocytes. Studies using the selective inhibitor wortmannin